# Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands

## TL;DR

This study creates and tests new dimeric versions of a neuropeptide that could lead to more effective and longer-lasting drugs targeting a key receptor involved in various physiological functions.

## Contribution

The synthesis of disulfide-linked homodimeric nociceptin/orphanin FQ derivatives with enhanced potency and duration.

## Key findings

- Compound 1h showed a pEC50 > 9, making it highly potent in vitro.
- In vivo, 1h was three times more potent than N/OFQ in inducing loss of the righting reflex in mice.
- The effect of 1h lasted up to 7 hours, indicating a long-lasting action.

## Abstract

The neuropeptide nociceptin/orphanin FQ (N/OFQ) plays
a key role
in regulating several physiological functions and pathological states,
which makes its receptor (NOP) a promising target for therapeutic
interventions. In this study, we synthesized homodimeric N/OFQ-NH2 derivatives linked by disulfide bonds between cysteines appropriately
introduced in the addressing region of the native peptide in place
of the original amino acids. The in vitro activity
of the compounds was evaluated using both an NOP-G protein interaction
BRET assay and a calcium mobilization assay. The most potent compound, 1h (pEC50 > 9), was obtained by coupling two
monomeric
precursors via a Leu14-to-Cys substitution. In
vivo, 1h demonstrated 3-fold greater potency
than N/OFQ in eliciting loss of the righting reflex in mice and produced
a long-lasting effect monitored for up to 7 h, supporting multimerization
as a viable approach to developing long-acting peptide-based NOP ligands.